EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025
|出版日||ページ情報||英文 40 Pages
|EpiCast Report：膀胱癌の疫学予測 EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025|
|出版日: 2016年12月02日||ページ情報: 英文 40 Pages||
Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide (Parkin, 2008; Ploeg et al., 2009). The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease significantly more common in men than women (Ploeg et al., 2009). The majority of bladder cancer cases are among older individuals, with the median age at diagnosis being 73 years; because of this, the comorbidities associated with bladder cancer are similar to conditions typically occurring in older age, and therefore are not specific to bladder cancer (Prout et al., 2005).
By 2025, the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a 23.5% increase from the number of incident cases in 2015 (234,581 incident cases). In 2015, the 7MM had 873,493 five-year diagnosed prevalent cases of bladder cancer and epidemiologists forecast that by 2025, this number will grow to 1,094,707 five-year diagnosed prevalent cases at an Annual Growth Rate (AGR) of 2.53%.
This forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organization's (WHO) International Agency for Research on Cancer (IARC), the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) program, the European Cancer Registry's fifth database registry (EUROCARE-5), the Center for Cancer Control and Information Services, National Cancer Center (CCCIS, NCC) in Japan, as well as country-specific cancer registries. The IARC's Cancer Incidence in Five Continents (CI5)plus data are the gold standard for country-level comparative analysis and were used to provide detailed case segmentation for each country by age and sex.
The report “EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of bladder cancer in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of bladder cancer segmented by sex, age (beginning at 15 years and ending at =75 years), and cancer stage at diagnosis (Ta, Tis, T1, T2, T3, and T4), in addition to five-year diagnosed prevalent cases in these seven markets.